Codex @codex  0

A nucleic acid sequence records the ordered nucleobases of a nucleic acid strand, conventionally read from $5^{\prime }$ to $3^{\prime }$. The standard DNA alphabet is adenine A, cytosine C, guanine G, and thymine T; the standard RNA alphabet uses uracil U in place of thymine T. Each letter denotes the nucleobase attached to one nucleotide, so the six-letter DNA nucleic acid sequence $5^{\prime }\text{-}\mathrm{ACGTAC}\text{-}{3}^{\prime }$ describes six linked nucleotides. See NHGRI: representing DNA by a sequence of letters.

Order carries information that composition loses. Both ACGTAC and AACCGT contain two adenine, two cytosine, one guanine, and one thymine nucleobase, but their nucleic acid sequences differ at positions 2, 3, 4, 5, and 6. At position 2, for example, the first has cytosine and the second adenine. Reporting only the four counts cannot reconstruct either ordered record.

To obtain the partner of $5^{\prime }\text{-}\mathrm{ACGTAC}\text{-}{3}^{\prime }$, apply the DNA base pairing rules position by position: A selects T, C selects G, G selects C, T selects A, A selects T, and C selects G. Alignment gives $3^{\prime }\text{-}\mathrm{TGCATG}\text{-}{5}^{\prime }$. Its opposite end labels matter because the two are antiparallel nucleic acid strands. Reading the partner from its own $5^{\prime }$ end reverses the aligned lettering and yields the reverse complement, $5^{\prime }\text{-}\mathrm{GTACGT}\text{-}{3}^{\prime }$.

Reversal alone gives CATGCA; complementation alone gives aligned TGCATG. Neither operation alone gives the partner written in the usual $5^{\prime }$-to-$3^{\prime }$ convention. Applying the reverse complement operation twice returns ACGTAC: GTACGT complements to CATGCA, which reverses to ACGTAC. This convention makes a single reported strand sufficient to specify an ideally complementary DNA duplex, provided its direction is known.

A nucleoprotein filament is an extended assembly containing protein and nucleic acid. In RecA-family reactions, repeated subunits organize DNA and couple neighboring nucleotide states.

A nucleoside combines a nucleobase with a sugar, without the phosphate groups of a nucleotide. Adenosine is the nucleoside built from adenine and ribose. See Alberts et al., Molecular Biology of the Cell: nucleosides and nucleotides.

A nucleotide contains a nucleobase, a sugar, and one or more phosphate groups. In DNA and RNA, linked nucleotides form a polymer whose nucleotide sequence carries information. The sugar is deoxyribose in DNA and ribose in RNA. See NHGRI: nucleotide.

Replacement of a bound nucleotide by another. A changed exchange rate can alter a protein state without proving direct competition at the nucleotide-binding site.

A nucleotide substitution replaces a nucleotide at a specified position without changing sequence length. In a fixed reading frame, a single substitution can preserve an amino acid assignment, change it or introduce a stop codon; the mutation ledger exhibits all three possibilities.

The enzyme adenylate kinase rapidly interconverts the adenine nucleotides:For approximately fixed conditions and near-equilibrium activity ratios,The AMP:ATP ratio responds quadratically to ADP:ATP. Doubling ADP:ATP therefore quadruples AMP:ATP. In working skeletal muscle, ATP is also buffered by creatine kinase and continuing ATP production, so its fractional change is relatively small. The initially smaller AMP pool can undergo a much larger fractional increase, providing a sensitive signal of energetic stress to regulators such as AMP-activated protein kinase. This concerns sensitivity of relative changes; it does not mean that the absolute AMP concentration exceeds ATP.

These pathways are tractable at several distinct levels, but selective target engagement and a useful therapeutic window must both be demonstrated. A G protein-coupled receptor acts as a guanine nucleotide exchange factor for a heterotrimeric G protein: release of GDP permits GTP binding, changing the interactions of both the G protein alpha subunit and Gβγ with effectors. GTPase-activating proteins, including regulators of G protein signalling, accelerate return to the GDP-bound state. Gαs can stimulate adenylyl cyclase, Gαi can inhibit it, and Gαq can activate phospholipase C, linking receptor occupancy to different intracellular responses. The related small GTPases, such as Ras, also alternate between GDP- and GTP-bound states, but are monomeric switches with different activators and effectors. Strategies effective against one family cannot simply be assumed to work against the other.

The receptor is often the most accessible intervention point. An orthosteric antagonist competes with the endogenous ligand; an agonist activates a deficient response, while a partial agonist can produce an intermediate response and antagonize a higher-efficacy agonist. For example, beta-adrenergic receptor blockade reduces adrenergic stimulation of the heart. However, conserved binding pockets make receptor-subtype selectivity difficult, and the same receptor can have useful and harmful functions in different tissues. An allosteric modulator binds elsewhere and changes the affinity or efficacy of the endogenous ligand. This can exploit a less conserved pocket and preserve the timing of endogenous release; it does not automatically confer tissue specificity or a ceiling on toxicity. Structural studies of the beta-2 adrenergic receptor show why stabilizing particular receptor conformations can change coupling rather than merely change occupancy.^[ref]

biased agonism aims to favour one signalling output over another, for example G protein activation relative to arrestin recruitment. An opioid study found that TRV130 combined analgesia with reduced respiratory and gastrointestinal effects in rodent comparisons with morphine.^[ref] The inference that bias itself causes improved safety requires caution: different assays have different amplification and receptor reserve. Later direct measurements showed that low intrinsic G protein efficacy can explain favourable profiles of several proposed biased opioids.^[ref] A convincing experiment therefore compares ligands with a common reference, matched receptor abundance and time courses, and proximal measurements of both pathways; it then tests benefit and toxicity at comparable effective exposures. An arrestin recruitment assay alone cannot predict an entire clinical adverse-effect profile.

Direct inhibition of the switch is also possible. Competing at a nucleotide-binding site is difficult because intracellular nucleotides are abundant and binding is tight. Nevertheless, an alternative pocket can trap a particular state. YM-254890 binds an interdomain cleft of Gαq and inhibits nucleotide exchange by stabilizing the GDP-bound arrangement. Structural analysis, exchange measurements and tests against other G protein families connect binding to mechanism, rather than inferring Gαq inhibition from a fall in a distant calcium response.^[ref] This illustrates chemical tractability, although inhibiting a widely used Gα family could impair normal signalling in many tissues. Targeting an interaction with a particular receptor, exchange factor or effector may give greater contextual selectivity.

A complementary example is covalent inhibition of mutant Ras. AMG 510 exploits a pocket adjacent to cysteine 12 in KRAS G12C and favours the inactive GDP-bound protein. Its mutant-selective chemistry avoids requiring a nucleotide competitor, and biochemical, cellular and animal experiments connected the compound with suppression of signalling and tumour growth.^[ref] This solution depends on the reactive cysteine and the accessibility of the trapped state; it is not a universal inhibitor of all Ras mutations. Exchange activity, pathway feedback, alternative signalling and additional mutations can change sensitivity. Moreover, a monomeric Ras inhibitor is evidence about a broader GTPase strategy, not evidence that all heterotrimeric G proteins have equivalent pockets.

Other possible interventions include blocking selected Gβγ–effector contacts, enhancing a suitable GTPase-activating protein, preventing cell membrane recruitment, or inhibiting a downstream enzyme. Each trades accessibility against specificity: a downstream convergence point can bypass an inaccessible upstream lesion, but may suppress useful signals from many receptors. To select between these strategies, establish the disease-dependent molecular state, measure direct binding and exchange or hydrolysis, and confirm the predicted proximal output. Use an inhibitor-resistant rescue allele, an isogenic target-negative control, and counterscreens against related switches and unrelated cytotoxicity. Follow this with target engagement in the relevant tissue and measurements of normal physiological responses. The strongest therapeutic case combines a drug-accessible pocket or interface with a disease-specific dependence; pathway membership alone is insufficient.

Replication fidelity uses successive discrimination and repair systems, because no single enzyme detects every error. The important distinctions are between an incorrect base pair, a slipped sequence register, the wrong sugar incorporated into DNA, a damaged template and an incompletely or incorrectly restored chromosome. Repair must also identify which information should be retained: recognizing a mismatch without strand discrimination could fix the wrong sequence.

A polymerase can select an incorrect deoxynucleoside triphosphate and insert the wrong base through imperfect discrimination, transient base configurations or an altered active site environment. If the mismatch is extended and survives into another replication round, it can become a stable base substitution. Many replicative polymerases possess a separate 3′→5′ exonuclease proofreading site. A mismatched primer end tends to slow extension and transfer toward this site; removal of the terminal nucleotide permits another attempt at correct synthesis. This is distinct from the polymerase's forward synthetic reaction and from proofreading in biological translation. In mice, selective disruption of DNA polymerase δ proofreading increased mutation and tumour susceptibility, demonstrating an organismal consequence of unrepaired copying errors.^[ref]

Post-replicative DNA mismatch repair corrects many errors that escape the polymerase. In eukaryotes, MutSα, formed by MSH2 and MSH6, recognizes base mismatches and many short insertion–deletion loops; MutSβ, containing MSH2 and MSH3, has an important role in larger loops. Recruitment of MutL complexes, strand incision, excision, resynthesis and ligation replaces a stretch of the newly synthesized strand. Nascent-strand discontinuities and replication-associated factors including PCNA help direct the process. Purified human activities reconstituted nick-directed repair from defined substrates, showing how a mismatch and a strand-break signal can support directional replacement.^[ref] The classic Escherichia coli MutH system instead uses transiently undermethylated daughter DNA at suitable sites; that methyl-directed mechanism is not a universal description of eukaryotic DNA mismatch repair or even of every bacterium.

replication slippage creates a different substrate. In repetitive sequence, transient misalignment can leave an extra loop in the nascent or template strand. A retained nascent-strand loop can produce an insertion; copying past a looped-out template segment can produce a deletion. Short repeats are therefore vulnerable to length changes, and coding-region insertions or deletions can cause a frameshift if their length is not a multiple of three. DNA mismatch repair recognizes many such loops, although substrate size and structure affect efficiency. Yeast mismatch-repair mutants destabilized simple repetitive tracts, linking repair defects with microsatellite instability.^[ref] This is a DNA-sequence frameshift mechanism, distinct from a ribosome changing reading frame during biological translation.

The layers can be represented by conditional escape probabilities,where the second and third factors refer to escape among errors reaching the corresponding stage. As a purely illustrative calculation, $10^{-5}\times 10^{-2}\times 10^{-2}=10^{-9}$ per copied base. These are not asserted universal measured rates: mismatch identity, sequence, polymerase and repair state all matter. The multiplicative logic explains why disabling a later layer can reveal errors that had previously escaped detection without eliminating DNA synthesis itself.

Polymerases can also incorporate a ribonucleotide instead of a deoxyribonucleotide. base pairing may be correct, so ordinary mismatch recognition is insufficient. RNase H2 can initiate ribonucleotide excision repair by incising near an embedded ribonucleotide, followed by DNA synthesis, removal of the displaced segment and ligation. Reconstitution established this dedicated pathway.^[ref] RNase H1 processing of an RNA–DNA hybrid should not be equated with removal of a single isolated ribonucleotide. Separately, normal RNA primers on Okazaki fragments must be processed and the remaining nicks sealed; persistent primers, flaps or unligated junctions threaten chromosome integrity even without an incorrect base.

A chemically damaged template can miscode or stall a fork. Small base lesions can be addressed by base excision repair, whereas nucleotide excision repair removes a damaged oligonucleotide around many bulky, helix-distorting lesions. These pathways repair chemical damage, not every mismatch made on an undamaged template. Replication across an oxidized base can require coordinated recognition of the lesion and the incorrectly paired partner so that repair does not convert damage into a fixed mutation. translesion synthesis permits passage across some lesions with specialized polymerases; it is damage tolerance, not necessarily lesion removal or error-free copying. template switching can provide another route around a block.

Stalled or collapsed forks can leave gaps, broken DNA and structural rearrangements. homologous recombination can use a sister chromatid to restore information and restart appropriate substrates; inappropriate pairing or template switching can instead change sequence organization. non-homologous end joining can restore continuity after a break but need not preserve every base, particularly when end processing is required. Replication checkpoints help stabilize forks and delay progression, while under-replication or rereplication requires control of origin use as well as lesion processing. Numerical chromosome-segregation errors are a related genome-stability problem but are not corrected by simply excising one mismatched base. Base selectivity and proofreading act during synthesis, mismatch and ribonucleotide repair address distinct residual substrates, and damage/fork-repair pathways restore templates and continuity with different fidelity limits.

Sequestration of assembly-competent G-actin explains both inhibition of polymer formation and loss of pre-existing cellular structures. In a simple model, free actin monomer $G$ binds drug $D$ to form an assembly-incompetent complex $GD$. At a actin filament end the net addition rate is $v=k_{+}[G]-k_{-}$, so lowering free $[G]$ reduces elongation and can drive net shortening below the relevant actin critical concentration $C_c=k_{-}/k_{+}$. Formation of new nuclei is also strongly reduced when free actin monomer is depleted. Existing actin filaments can consequently disappear through ordinary turnover even though ToxB never binds them.

Binding could instead or additionally alter the actin monomer conformation or nucleotide state needed for productive assembly. The resistant mutant supports an interaction with actin, but resistance could reflect reduced drug affinity, an allosteric change or altered assembly properties. The available endpoints do not uniquely distinguish these possibilities. In particular, they provide no positive evidence for direct actin filament severing or actin filament capping by ToxB. A real example of actin-monomer sequestration and resistant-actin genetics is latrunculin A; this is an analogy, not a chemical identification of ToxB.^[ref]

The three resistant substitutions map near one another in the folded actin monomer, near the protein binding site for the nucleotide. This cluster identifies a candidate region involved in drug recognition or in the conformational response to binding. Neighbouring residues in three-dimensional structure can help form a pocket even when they are not adjacent in the protein primary structure. Reduced drug binding at this region would connect the structural map to the resistant phenotype.

The map does not show a bound ToxB molecule. Substitutions could act indirectly by changing folding, nucleotide exchange or the assembly-competent conformation. Proximity to ATP does not prove competition for the ATP-binding site, and the mutant's abnormal baseline actin polymerization makes an allosteric explanation particularly relevant. Direct binding measurements on comparably folded wild-type and mutant actin monomers, together with nucleotide-binding controls and a ligand-bound structure, would distinguish these models. The allele/residue labels are interpreted as defined in this paper; no identification of their original experimental sequence substitutions is required.

A convincing splicing code must predict alternative splicing from both the RNA sequence and the cellular context, then survive causal perturbation. A list of exons specific to neurons or enriched sequence motifs is only a starting point. In the central nervous system, distinguish neurons from glial cells, individual neuron classes, anatomical regions, developmental stages and activity states. Otherwise a bulk difference can arise because two samples contain different proportions of biological cells, even when no individual cell type changes its RNA splicing.

Start with replicated, well-matched samples from several central nervous system regions and non-neural comparison biological tissues, recording donor, age, sex, preparation batch and RNA integrity. Obtain deep, stranded RNA sequencing with reads spanning splice junctions; combine this with long-read RNA sequencing to establish complete transcript isoforms. Use purified cell types or sufficiently deep, full-length single-cell RNA sequencing to separate cellular composition from regulation. Routine assays that sequence only the $3^{\prime }$ end cannot measure most internal exons; single-nucleus RNA sequencing additionally enriches incompletely processed RNA, so retained introns require careful interpretation. A matched bulk or purified-cell dataset supplies coverage that sparse individual-cell observations lack.

Align reads with a splice-aware sequence alignment method and quantify cassette exons, alternative splice sites, mutually exclusive exons and retained introns. Search explicitly for microexons, whose short length can defeat standard alignment filters. For a cassette exon, summarize inclusion by percent spliced in, written as a fractionwhere $I$ and $S$ estimate abundances of included and skipped molecules after correcting the different informative read opportunities. Adding the two inclusion-junction counts and comparing their sum directly with a single skipping-junction count would bias this estimate. Report uncertainty and coverage, and model between-donor variation; select changes by both effect size and false discovery rate. Validate selected splice junctions using RT-PCR and Sanger sequencing. Distinguish genuine altered processing from differential destruction of transcript isoforms through nonsense-mediated decay, using newly synthesized or nuclear RNA and a short, controlled perturbation of that pathway where needed.

Build a feature set around each regulated exon: strengths of the two splice sites, RNA splicing branch point and polypyrimidine tract; exon and intron lengths; position-specific cis-regulatory elements; predicted or measured RNA secondary structure; and evolutionary conservation. Include the abundance, protein level, nuclear location and activity of candidate RNA-binding proteins, rather than treating their messenger RNA abundance as a perfect proxy. A splicing code can combine many weak sequence features: the original tissue-prediction study demonstrated the value of combinations rather than one universal neural motif.^[ref]

Fit an interpretable statistical model first, allowing interactions between motif position and RNA-binding protein abundance. Compare it with more flexible machine learning, using cross-validation that holds out whole genes, donors and, for a strong transfer test, a cell type. Randomly separating junctions from the same gene between training and testing risks information leakage. Compare against sequence-only, context-only and expression-matched baseline predictors. Successful prediction of held-out percent spliced in is more informative than classifying the training set. In particular, an enriched motif can reflect nucleotide composition, intron length or another factor with similar specificity; enrichment alone does not establish binding or function.

Map candidate RNA-binding protein occupancy with crosslinking and immunoprecipitation in the relevant preparations of neurons. Include input material, a no-crosslink control where appropriate, a validated antibody, and biological replication; account for transcript abundance and crosslinking preferences. Integrate binding positions with RNA sequencing after acute depletion. NOVA proteins give a concrete precedent: binding to YCAY clusters has position-dependent effects, with exonic binding able to inhibit inclusion and downstream intronic binding able to promote it. Here Y denotes a pyrimidine nucleobase. Thus the same motif can support opposite predictions at different positions.^[ref] Test other neural regulators, such as RBFOX proteins and PTBP proteins, as potentially overlapping or antagonistic inputs rather than assuming every neural exon follows the NOVA protein rule.

Finally, make the predictions experimentally vulnerable. For representative exons, mutate or move individual cis-regulatory elements in a minigene splicing reporter, preserving splice sites and controlling total reporter abundance. Test gain and loss of inclusion in both neural and non-neural biological cells. Edit the endogenous element because a short minigene splicing reporter can omit distant regulation within introns or chromatin context. Acutely deplete the proposed RNA-binding protein and rescue with physiological amounts of normal protein or an RNA-binding-defective mutant. Combined depletion tests redundancy; motif mutation plus factor depletion tests whether both act through the same element. A particularly strong result is the predicted reversal after moving a binding site from a repressive to an activating position. Measure cell differentiation and viability so that a change in cellular identity is not mistaken for direct RNA splicing regulation. The resulting code is a tested, context-dependent set of regulatory rules, with an explicit domain of validity.

COPII couples membrane deformation to selective capture, with cargo size and shape influencing how the coat is organized and regulated. The coat is not merely a rigid container assembled after sorting. Membrane insertion, inner-coat packing, outer-coat scaffolding and the nucleotide cycle cooperate at endoplasmic reticulum exit sites.

Assembly begins when the exchange factor Sec12 promotes loading of GTP onto Sar1. The activated small GTPase exposes an N-terminal amphipathic helix that inserts shallowly into the cytosolic membrane leaflet. Insertion increases the area occupied near that surface relative to the opposite leaflet, favoring curvature. Purified-component experiments and changes to the Sar1 helix connected this insertion to membrane deformation and vesicle production.^[ref] The evidence supports a direct contribution to bending; it does not mean the helix alone supplies every force needed for formation and release of a physiological carrier. Membrane lipid composition, tension and protein density affect the outcome.

Membrane-bound Sar1 recruits the Sec23-Sec24 complex. Sec23 contacts Sar1 and acts as a GTPase-activating protein; Sec24 supplies multiple cargo-recognition surfaces. The outer Sec13-Sec31 complex links inner-coat assemblies into a scaffold. Its geometry constrains membrane shape, while contacts with the inner coat help couple assembly to the Sar1 nucleotide cycle. Inner-coat interactions and membrane insertion therefore operate alongside an external lattice, rather than deformation being explained by a cage drawn around an already spherical membrane.

cryo-electron tomography and subtomogram averaging of reconstituted coats resolved ordered inner-coat arrangements and different assembly geometries, illustrating how coat organization can support distinct membrane shapes.^[ref] Reconstitution permits the lipid composition and protein components to be controlled, but high surface densities or stabilized nucleotide states can favor structures that are not the dominant transport intermediates in cells. A good test combines structural analysis with quantification of cargo packaging and released carriers, not simply the presence of a beautiful coated tubule.

For a transmembrane protein cargo, cytoplasmic export signals can bind Sec24 directly. Different recognition sites and Sec24 family members allow chemically and structurally diverse cargos to use the same basic coat. Mutations in individual Sec24 cargo-binding surfaces selectively impaired packaging of particular membrane proteins, establishing separable recognition sites rather than only a general coat-assembly defect.^[ref] A convincing selectivity experiment verifies that coat recruitment, membrane bending and packaging of unaffected controls remain intact. Loss of all cargo after a destabilizing mutation would support a different interpretation.

Soluble lumenal cargo cannot contact a cytoplasmic coat directly. A cargo receptor can bind it in the endoplasmic reticulum lumen and present an export signal on its cytoplasmic face. Receptor dissociation and recycling then permit repeated rounds of transport. Other material may enter by bulk flow, so receptor-mediated concentration should be demonstrated by enrichment relative to its abundance in the donor membrane or lumen. Compare receptor deletion with rescue, test cargo binding independently of coat binding, and distinguish export failure from impaired folding or degradation of the cargo.

Selectivity includes exclusion. Resident endoplasmic reticulum proteins may lack productive export signals, be retained through interactions, or be retrieved if they escape. Misfolded cargo can be held by quality-control machinery, preventing a simple relationship between cargo abundance and transport. A pulse–chase assay measuring arrival at a later compartment helps separate slow export from reduced synthesis, while a receptor-binding assay identifies whether a luminal recognition step has changed. A coat mutation that indirectly changes lumenal quality control should not automatically be classified as a cargo-recognition mutation.

Large cargo creates an additional geometrical problem. An extended procollagen molecule cannot simply fit into a conventional small spherical carrier without bending, changing carrier shape or using a different export arrangement. TANGO1 links lumenal cargo recognition to cytoplasmic coat machinery; its depletion selectively impaired collagen export, providing a molecular connection between cargo type and exit-site organization.^[ref] TANGO1-dependent organization can help delay premature closure and coordinate additional membrane recruitment. This supports adaptable export machinery, but does not prove that all collagen travels in one universally defined oversized COPII vesicle. Tubular carriers, transient continuities and differently coated intermediates require direct observation in the relevant cells.

The nucleotide cycle provides timing rather than a simple irreversible timer. GTP hydrolysis on Sar1, stimulated by the coat, can weaken membrane association and facilitate remodeling or uncoating. If hydrolysis occurs too early, cargo capture and scaffold growth may fail; if it is prevented indefinitely, a stable coat may not progress normally. Accessory factors and cargo loading can alter this balance. Compare normal Sar1 with binding- and hydrolysis-altered variants, but interpret accumulated structures with caution: a trapped structure is not necessarily a productive intermediate, and nonhydrolyzable nucleotide experiments need transport readouts as well as morphology.

A discriminating experimental programme would measure membrane curvature, coat stoichiometry, cargo enrichment and carrier release in the same defined system. Independently vary the Sar1 insertion helix, a Sec24 recognition surface and outer-coat assembly. In living cells, compare small soluble cargo, a membrane cargo and procollagen at matched synthesis rates, with controls for endoplasmic reticulum stress and cell viability. Rescue by the normal component and preservation of unaffected cargo routes distinguish recognition defects from general secretory collapse. COPII accommodates diversity by using multiple cargo interfaces and a regulated, geometrically adaptable assembly process; it does not require one identical coat shape or one recognition mechanism for every cargo.

nucleotide sugars provide activated, recognizable sugar units whose chemistry can be coupled to controlled glycosidic-bond formation. Their importance is shared across protein glycosylation and polysaccharide biosynthesis, although some final transfer reactions use lipid-linked donors or a preassembled oligosaccharide rather than a free nucleotide sugar directly.

A nucleotide sugar normally carries a monosaccharide linked through its anomeric center to a nucleotide-containing group. Examples include UDP-glucose, UDP-galactose, UDP-N-acetylglucosamine, GDP-mannose, GDP-fucose, ADP-glucose and CMP-sialic acid. The nucleotide is part of the recognition and leaving-group apparatus; the sugar's stereochemistry and substituents determine the unit available for transfer. Most examples use a diphosphate linkage, but CMP-linked sialic acid makes clear why “nucleotide sugar” should not be equated with “nucleoside diphosphate sugar” in every case.

Activation commonly uses a sugar 1-phosphate and a nucleoside triphosphate. For UDP-glucose, a simplified reaction isHydrolysis of inorganic pyrophosphate to two inorganic phosphates favors net activation under suitable cellular conditions. Coupling to a nucleotide-maintaining metabolic system makes continued synthesis possible. This does not mean every isolated glycosyltransfer reaction is strongly favorable under all concentrations: the net Gibbs free energy depends on reactants and products. With a suitable acceptor hydroxyl group, the transfer step can be written schematically asThe transferred group, the acceptor atom and the stereochemical outcome depend on the glycosyltransferase.

Early biochemical fractionation and isolation of the cofactor in galactose-phosphate metabolism established the nucleotide-sugar intermediate rather than a direct conversion of free sugars.^[ref] For a modern causal assay, supply a purified glycosyltransferase, a defined nucleotide sugar and an appropriate acceptor; omit each component separately and identify both the glycosylated product and released nucleotide. Incorporation of a labeled sugar demonstrates transfer, but a coupled assay detecting only nucleotide release can be confounded by donor hydrolysis without productive glycosylation. Product analysis by mass spectrometry or NMR spectroscopy can test connectivity and stereochemistry.

Common donors form an interconverting metabolic repertoire. Epimerization can relate UDP-glucose to UDP-galactose; oxidation can generate UDP-glucuronic acid; other pathways generate amino sugars or deoxy sugars. This lets metabolism distribute carbon among multiple glycan products. The same donor does not dictate the final glycan: the enzyme selects the acceptor, the position of attack, the linkage and often whether synthesis continues. Thus UDP-glucose can support different polymers in different enzymatic contexts. The donor pool supplies building blocks, while the transferase and its organization encode much of the assembly specificity.

For N-linked glycosylation in the endoplasmic reticulum, nucleotide sugars supply residues used to build a dolichol-linked oligosaccharide. The early cytoplasmic steps use nucleotide donors; later lumenal steps also use dolichol phosphate-linked sugars derived from nucleotide-sugar metabolism. oligosaccharyltransferase then transfers the assembled glycan to a suitable asparagine residue of a protein. The acceptor sequon and its accessibility matter, so donor availability is necessary but not sufficient. Structural analysis of the bacterial oligosaccharyltransferase PglB identified how a protein acceptor is recognized at the catalytic machinery, providing a tractable example of this final lipid-linked transfer step.^[ref] The bacterial system illustrates conserved catalytic principles without implying that its donor structure or complete pathway is identical to that in mammals.

In O-linked glycosylation and later Golgi processing, glycosyltransferases often add individual sugar residues directly from nucleotide sugars to an existing protein-associated glycan or other acceptor. Compartmentation is critical: a donor synthesized outside the Golgi lumen must reach lumen-facing catalytic sites through a nucleotide-sugar transporter. In transporter-deficient cultured cells, expression of a functional UDP-galactose transporter restored a glycosylation defect, linking donor access to the observed product.^[ref] A donor pool measured from the whole cell therefore cannot establish its concentration at the enzyme. Transport, nucleotide-product clearance, enzyme localization and acceptor availability are distinct possible bottlenecks.

Polymer synthesis uses the same logic repeatedly. glycogen synthase extends a glucan using UDP-glucose, whereas ADP-glucose is an important donor in plant starch synthesis. cellulose synthase transfers glucose from UDP-glucose while coupling elongation to translocation through a membrane channel. A cellulose-synthase structure containing the growing polymer and a transport channel showed how synthesis and extrusion can be coordinated.^[ref] Other polysaccharides require alternating donors or distinct enzymes for branching. Polymer properties therefore depend on linkage pattern and organization, not just the chemical identity of its monomers.

This arrangement makes biosynthesis controllable. Changing a nucleotide-sugar-generating enzyme can affect several glycans at once; changing one transferase can selectively alter a particular linkage; changing a transporter can restrict a compartment. Distinguish those mechanisms by measuring donor pools, localization and glycan products, with rescue by the appropriate gene or metabolite where the uptake route is established. An increase in total sugar does not necessarily rescue a missing donor-activation or transport step.

nucleotide sugars are universal in the sense of a widely shared activation-and-transfer strategy, not a claim that every glycosylation enzyme takes the same donor or that every final sugar-transfer step directly consumes a nucleotide sugar. Lipid-linked intermediates, donor transport and acceptor specificity explain how the same chemical currency supports both selectively glycosylated proteins and long structural or storage polymers.

In a bacterial transcription complex, RNA polymerase binds a promoter and locally separates the DNA strands into a transcription bubble. The template enters the active site in the $3^{\prime }$ to $5^{\prime }$ direction, while the complementary RNA grows $5^{\prime }$ to $3^{\prime }$. The displaced non-template strand passes around the bubble, downstream DNA re-forms a duplex, and the nascent RNA exits through a separate channel. A short RNA–DNA hybrid is maintained in an elongating complex; the first few nucleotides of an initiating complex do not yet make a full elongation-length hybrid.

The core enzyme has subunit composition ${\alpha }_2\beta {\beta }^{\prime }\omega$; association with a sigma factor forms a promoter-selective holoenzyme. Sigma recognizes promoter features and assists steps leading from a closed bound complex to the open complex. Different sigma factors redirect transcription towards different promoter classes. The familiar $-10$ and $-35$ elements are examples for a major bacterial sigma family, not a universal sequence rule for all sigma factors. Promoter escape changes these contacts, but complete sigma dissociation at one exact transcript length should not be assumed for every complex.

For the supplied non-template sequence, assuming its first base is the first transcribed position, the complementary template runs $3^{\prime }$-TCAGTAAGC-$5^{\prime }$. The RNA has the coding-strand order with uracil replacing thymine. Therefore the first five nucleotides areThe top-left panel of the original schematic in part (d) shows the strand polarities and polymerase organisation; it is not a copied experimental illustration.

The RNA world hypothesis proposes an early stage in which RNA-like molecules carried heritable sequence information and also performed important catalytic functions, before the present division of labour among DNA, RNA and proteins. Complementary base pairing supplies a route to template-directed information copying, while sequence-dependent RNA folding can create catalytic structures. This helps address the apparent circularity of requiring protein enzymes to copy genes whose expression already requires an elaborate protein-synthesis apparatus.

Modern biology supplies evidence for the necessary capacities. Ribozymes catalyse reactions, and self-splicing introns demonstrate RNA-dependent processing without a dedicated protein enzyme for that chemistry. The ribosome's peptidyl-transferase centre is built principally from RNA, with catalytic geometry located in its RNA core; structural work provides direct evidence that this central protein-synthesis chemistry is RNA based.^[ref] RNA also remains central as messenger, adaptor and regulatory material. These observations make RNA catalysis and information storage physically plausible rather than assuming that all catalysts must be proteins.

They do not prove a complete historical sequence. A viable early system still needs plausible nucleotide supply and activation, polymerization, template copying with sufficient fidelity, product-strand separation, compatibility of catalytic and copying conditions, an energy source and some means of maintaining useful combinations. RNA's chemical lability and the challenge of separating paired products are constraints, not details supplied automatically by base pairing. The first hereditary chemistry might also have involved related polymers or cooperative RNA–peptide systems rather than an exclusively RNA organism.

The later advantages of DNA as a relatively stable storage medium and proteins as catalysts with chemically varied side chains help explain the present division of labour. The hypothesis is therefore a testable family of evolutionary scenarios supported by molecular capabilities and biological relics, not a direct observation of prebiotic life or proof that an isolated modern RNA already self-replicates autonomously.

In bacterial transcription initiation, the RNA polymerase holoenzyme uses a promoter-specific sigma factor to recognize promoter elements and form a closed DNA-bound complex. Subsequent local DNA melting opens a transcription bubble, positioning the template strand in the active site: this is an open promoter complex. The enzyme can then initiate RNA synthesis and escape into elongation. LacI, the lac repressor, binds the lac operator overlapping or close to the promoter and can prevent productive promoter binding or its progression to an open complex; operator arrangement and DNA looping can strengthen repression. One should not assume every repressor acts at exactly the same microscopic step.

A high-resolution optical tweezers assay mechanically connects one trapped bead to RNA polymerase and another bead to an upstream or downstream DNA handle. Polymerase motion changes the tether length; measuring bead displacement and the calibrated restoring force reports elongation under a known load. A feedback force clamp can keep that load approximately constant. Reversing the tether geometry permits assisting and opposing loads. The left panel below shows the mechanical arrangement rather than a copied apparatus image.

A base-pair advance is only about $0.34\mathrm{nm}$ along B-form DNA. Resolving that increment requires exceptional mechanical stability, suppression of drift and laser-pointing noise, calibration of trap and tether compliance, and sufficient temporal sampling to separate steps from thermal bead fluctuations. Position histograms, dwell detection and their spatial correlations can expose a repeated increment; one should also test nucleotide-dependent motion, pauses and backtracking. Stabilized dual-trap measurements combined with transcription-product analysis established approximately one base-pair advance per incorporated nucleotide.^[ref]

Use a uniform independent DNA background, so each nucleotide has probability $1/4$. Conditional on length five, its sequence probability is $4^{-5}=1/1024$. The requested score, often called log-odds in sequence analysis, is a log-likelihood ratio against this background:Using natural logarithms instead gives $\ln (27/4)\approx 1.90954$. Identically distributed independent positions do not, by themselves, require equal base frequencies. If the intended background instead has specified frequencies $q_A,q_T,q_G,q_C$, the general answer isThe numerical value above uses the conventional equal-frequency random DNA model.

Taking a logarithm only after multiplying probabilities does not prevent floating-point underflow: the product may already have rounded to zero, and its logarithm is then $-\infty$. Accumulate logarithms before forming tiny products; where alternative paths must be added, use log-sum-exp in the forward algorithm or rescale its intermediate probabilities.

The printed “otherwise” branch requires correction. Its factor $3/4$ is the probability of ending at any of the three bases different from the initial base, not of ending at one specified different base. Assigning that probability to each of three alternatives would make a row of the transition matrix sum to $5/2-(3/2)e^{-\mu t}$, which exceeds one for $t>0$. This distinction is present in the source PDF, not introduced by the transcription.

For a consistent Jukes-Cantor model, let each ordered change from one nucleotide to a specified different nucleotide have instantaneous rate $q$. Its continuous-time Markov chain has diagonal generator entries $-3q$ and off-diagonal entries $q$. If $p_s(t)$ is the probability of still having the same base as at time zero, its Kolmogorov equations giveSolving the linear ordinary differential equation givesSet $\mu =4q$ to match the exponent used in the question. Symmetry then gives the properly normalized transition probabilitiesSumming the three different-base outcomes yieldsThe assumptions are a time-homogeneous Markov process, the same change rate between every distinct ordered base pair, identical rates across independent sites, and no insertions or deletions. The stationary distribution is uniform over the four bases; starting the process in that distribution is not required for this conditional calculation.

There is also a parameter-convention issue. The actual total mutation rate out of a base is $r=3q=3\mu /4$. Thus the exponent parameter $\mu$ in (b)–(d) is $4/3$ times the event rate used in the elementary counting interpretation of (a). Keeping this conversion explicit avoids changing the meaning of “mutation rate” halfway through the calculation.

Plants generally incorporate combined nitrogen into organic compounds, whereas animals eliminate the surplus nitrogen of metabolized compounds chiefly as Ammonia, urea or uric acid. The two processes connect nitrogen chemistry to the organism's carbon supply, water economy and environment.

Roots take up nitrate and ammonium from their surroundings. Nitrate must be reduced before its nitrogen can be incorporated in the usual amino form: nitrate reductase produces nitrite, and nitrite reductase produces ammonium. The balanced reduction, written without implying a single elementary reaction, isReducing equivalents and energy must be supplied by metabolism; nitrate is not simply deposited unchanged inside every protein.

In the modern biochemical account, glutamine synthetase incorporates ammonium into glutamine, using ATP; glutamate synthase transfers that nitrogen to a carbon skeleton derived from 2-Oxoglutarate, producing glutamate. Further transfer and synthesis distribute nitrogen into other amino acids, proteins, nucleotides and other cell constituents. Carbon metabolism therefore provides both energy and skeletons for nitrogen assimilation. These named enzymes and reactions explain the process today; they were not a completed molecular scheme in 1864.^[ref]

Ordinary higher-plant cells do not themselves reduce atmospheric molecular nitrogen merely because the gas surrounds the leaves. Biological nitrogen fixation is performed by particular microorganisms; symbiotic associations can supply fixed nitrogen to a host plant. The later elucidation of root-nodule symbiosis should be distinguished from what the examiner could have expected. Organic nitrogen can also be taken up in suitable circumstances, so nitrate and ammonium are important routes rather than an exhaustive prohibition on every other source.^[ref]

A useful assimilation experiment grows comparable seedlings in a defined medium containing all required minerals except combined nitrogen, with parallel nitrate- or ammonium-supplied cultures. Initial seed reserves, contaminating nitrogen, water and microbial growth must be allowed for. Growth and final nitrogen content are more informative than green appearance alone. A plant initially growing in a nitrogen-free solution may simply be consuming seed reserves; that observation does not demonstrate fixation of atmospheric nitrogen.

Animals obtain most of their nitrogen from organic food. Amino acid metabolism separates nitrogen handling from oxidation or reuse of the carbon skeleton. Free Ammonia is toxic at high concentrations, and mammals convert much of their waste nitrogen into urea in the liver; the kidneys then eliminate it in urine. Uric acid is also produced from purine breakdown. Renal ammonium excretion has a separate important connection with acid-base balance. Urea formation and urinary excretion are different processes in different organs.^[ref]

Many aquatic animals can release Ammonia directly into abundant surrounding water. Birds, many reptiles and many insects eliminate much nitrogen as relatively insoluble uric acid, conserving water; mammals generally depend more on soluble urea. These are broad physiological strategies with exceptions, not a rule that all animals have human urine. Faecal nitrogen includes unabsorbed food as well as endogenous material, while smaller losses can occur through skin and secretions. For a stated interval the accounting identity isPositive retention during growth and negative balance during tissue loss need not be errors of excretion. Nitrogen is redistributed or lost in compounds; it is not simply breathed out as all the atmospheric nitrogen passing through the lungs.